Two Maine biotech companies have announced news regarding recent changes, Portland Press Herald reports. Scarborough based Fluid Imaging Technologies, BAM member and developer of a specialized device which allows for viewing particles in fluid, just introduced the expansion of their highly popular product, FlowCam, in the 50th country, giving the company a footprint in 7 continents. Shifting gears, another biotech startup company, Biovation of Boothbay is closing its doors. After seven years of developing and marketing innovative anti-microbial fiber products, the startup has laid off employees and put its assets up for sale. “With any risk comes the possibility of failure” said Biovation’s CEO Kerem Durdag about the recent development “It is my strongest belief that we as a state have to culturally get comfortable with the idea of risk if we are to be economically viable and have multiplier (effects) for our kids. And hence we have to see the value of failure. We just have to.” Read full article
Related Posts
University of Maine recruiting homeowners for tick surveys
ORONO, Maine — With tick season upon us, researchers at the University of Maine want to know what Mainers are doing...
Maine’s oldest bioscience symposium turns 50 on MDI
Students and accomplished science leaders share research on Mt. Desert Island This April 20 marked the 50th anniversary meeting of the...
Husson University students, faculty share projects at 13th annual Research Showcase
BANGOR, Maine — Today marked Husson University’s 13th annual Research and Scholarship Day. Students and faculty members at Husson shared the...